News
FDA Rejects Regeneron’s Request to Expand EYLEA HD® Label
Pune, India | August 26, 2025 Regeneron Pharmaceuticals received a Complete Response Letter (CRL) from the FDA that denied its request to expand the EYLEA HD®
Read MoreIndustry Expert and Analysis
February 3, 2026
Pune, India | August 26, 2025 Regeneron Pharmaceuticals received a Complete Response Letter (CRL) from the FDA that denied its request to expand the EYLEA HD®
Read More